Japan's valsartan clinical trials shambles; time for fundamental changes.

Ozaki, Akihiko; Harada, Kayo; Murayama, Anju; Saito, Hiroaki; Sawano, Toyoaki; Tanimoto, Tetsuya; Shrestha, Sunil; Bhandari, Divya; Crump, Andy

Ozaki, Akihiko; Harada, Kayo; Murayama, Anju; Saito, Hiroaki; Sawano, Toyoaki; Tanimoto, Tetsuya; Shrestha, Sunil; Bhandari, Divya; Crump, Andy.

Afiliación

Ozaki A; Medical Governance Research Institute, Minato-ku, Tokyo, Japan.
Harada K; Department of Breast and Thyroid Surgery, Jyoban Hospital of Tokiwa Foundation, Fukushima, Iwaki, Japan.
Murayama A; Medical Governance Research Institute, Minato-ku, Tokyo, Japan.
Saito H; Medical Governance Research Institute, Minato-ku, Tokyo, Japan.
Sawano T; Department of Gastroenterology, Sendai Kosei Hospital, Sendai, Miyagi, Japan.
Tanimoto T; Department of Surgery, Jyoban Hospital of Tokiwa Foundation, Iwaki, Fukushima, Japan.
Shrestha S; Medical Governance Research Institute, Minato-ku, Tokyo, Japan.
Bhandari D; School of Pharmacy, Monash University Malaysia, Jalan Lagoon Selatan, Bandar Sunway, Selangor Darul Ehsan, Malaysia.
Crump A; Medical Governance Research Institute, Minato-ku, Tokyo, Japan.

Int J Health Plann Manage ; 38(3): 557-568, 2023 May.

Article en En | MEDLINE | ID: mdl-36794862

Asunto(s)

Valsartán; Masculino; Humanos; Valsartán/uso terapéutico; Japón

Palabras clave

Diovan; Lancet; clinical trial act; novartis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Valsartán Tipo de estudio: Guideline Límite: Humans / Male País/Región como asunto: Asia Idioma: En Revista: Int J Health Plann Manage Asunto de la revista: PESQUISA EM SERVICOS DE SAUDE / SERVICOS DE SAUDE Año: 2023 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google